India’s Shift to High-Value, Innovation-Led Pharma: Spotlight on GLP-1
India’s GLP-1 market opened up almost overnight. Semaglutide came off patent in March 2026, and multiple Indian manufacturers launched generics […]
GENERIC-SEMAGLUTIDE
Dr Reddy’s Gears Up for March Launch of Generic Semaglutide ‘Obeda’ in India
Dr Reddy’s Laboratories is preparing to introduce its generic semaglutide injection in India, likely to be marketed under the brand […]
